Patterns and Outcomes of Coronary Artery Disease in Chronic Kidney Disease: Comparative Prospective Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 900
- 试验地点
- 1
- 主要终点
- To study the anatomy and morphology of coronary artery lesions in CKD and compare these with non-CKD patients.
研究概览
简要总结
This study aims to delve into the trends of lesions in the coronary artery and clinical outcomes in patients with CAD, both with and without CKD, who are undergoing CAG prospectively. The main emphasis will be on assessing the anatomy, quantity, and types of lesions in CAD patients with CKD compared to those with normal kidney function. Additionally, the prevalence of CAD in CKD patients undergoing CAG will be contrasted with the non-CKD cohort, followed by evaluating the CV outcomes such as 3-point Major Adverse Cardiac Events (3P-MACE) that include CV death, nonfatal MI, nonfatal stroke, 4P-MACE (additionally including unstable angina), 5P-MACE (further inclusion of hospitalization for heart failure (HHF), Mortality, and progression of CKD in these patient demographics, offering an understanding of comparative risks and the necessity for specific management strategies in CKD populations. Finally, a subgroup analysis will be done by comparing the above outcomes among CKD patients with and without comorbidities.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients undergoing Coronary Angiogram for the first time at the KMC hospital.
排除标准
- •Participants who decline participation; having incomplete medical records or missing essential data, are pregnant, have a documented history of prior CAG, PCI, or coronary artery bypass grafting (CABG), have severe valvular heart disease, or have a critical illness with a life expectancy of less than one year will be excluded.
结局指标
主要结局
To study the anatomy and morphology of coronary artery lesions in CKD and compare these with non-CKD patients.
时间窗: 24 months
次要结局
- prevalence of CAD among CKD patients undergoing CAG and(compare it with non-CKD group with similar indications.)
- cardiovascular outcomes (3P-MACE), (4P-MACE), and (5P-MACE)(24 months)
- Comparison of (3P-MACE), (4P-MACE), (5P-MACE), Mortality, Progression of CKD among CKD patients with and without comorbidities(24 months)
研究者
Dr Ravindra Prabhu A
Kasturba Medical College, MAHE, Manipal
